Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

BACKGROUND: Immune checkpoint blockade (ICB) induces durable response in approximately 20% of patients with advanced bladder urothelial cancer (aUC). Over 50% of aUCs harbor genomic alterations along the phosphoinositide 3-kinase (PI3K) pathway. The goal of this project was to determine the synergis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Shaoming, Ma, A-Hong, Zhu, Zheng, Adib, Elio, Rao, Ting, Li, Na, Ni, Kaiyuan, Chittepu, Veera Chandra Sekhar Reddy, Prabhala, Rao, Garisto Risco, Juan, Kwiatkowski, David, Mouw, Kent, Sonpavde, Guru, Cheng, Fan, Pan, Chong-xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562536/
https://www.ncbi.nlm.nih.gov/pubmed/34725212
http://dx.doi.org/10.1136/jitc-2021-002917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562536/
https://www.ncbi.nlm.nih.gov/pubmed/34725212
http://dx.doi.org/10.1136/jitc-2021-002917

Ejemplares similares